Skip to main content
ConductScienceScienceDex

Pamela Anne Maher

NIH Rank #1188
Unclaimed recordClaim profile
  • Program Leader
  • R01 Holder
  • Top 10% Funded
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1894752Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2024

Linked Award Amount
$4.8M
Full award amounts, FY2024
Award Records
3
Records listing this PI
Award-Linked Rank
#1,188
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Pamela Anne Maher. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Pamela Anne Maher as a PI. Multi-PI records show the full award amount for context.

  • 1R44AG085775-01A1R44
    Paving the Way to Phase 2 Trials of CMS121 for Alzheimer's Disease
    Virogenics, Inc.
    $2.4M
    award amount
  • 1U01AG084549-01U01
    Long-term, non-clinical toxicology for advancing CMS121 to Phase 2 trials for AD
    Virogenics, Inc.
    $1.6M
    award amount
  • 5R01AG069206-05R01
    Using geroscience to understand and treat Alzheimer's disease
    Salk Institute for Biological Studies
    $769.1K
    award amount

Award organizations

Organizations that administered FY2024 awards listing Pamela Anne Maher as a PI.

Virogenics, Inc.
CA
$4M
2 grants
Salk Institute for Biological Studies
CA
$769.1K
1 grant

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Virogenics, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #1188
  6. 2024
    Entered Top 25% Nationally
    Ranked #1188
  7. 2024
    Entered Top 10% Nationally
    Ranked #1188
  8. 2025
    $5M Cumulative Funding
  9. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  10. 2025
    R01 Grant Holder
  11. 2025
    Program/Center Grant Leader

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Pamela Anne Maher.

William C Raschke
Virogenics, Inc.
3
shared awards
Salvador Soriano
Loma Linda University
1
shared award

Explore further

Find collaborators for Pamela Anne Maher

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →
Pamela Anne Maher | NIH Award Records | ConductScience